Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex

Human Molecular Genetics

Volumn 10, Issue 23, 2001, Pages 2651-2660

  Otsuki, Tetsuya ^a   Furukawa, Yusuke ^a   Ikeda, Keiko ^a   Endo, Hitoshi ^a   Yamashita, Takayuki ^b   Shinohara, Azusa ^c   Iwamatsu, Akihiko ^c   Ozawa, Keiya ^a   Liu, Johnson M ^d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KIRIN BREWERY CO LTD   (Japan)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BINDING PROTEIN; CHAPERONE; DNA; FANCONI ANEMIA PROTEIN; GENE PRODUCT; GLUCOSE REGULATED PROTEIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; BIRTH DEFECT; CANCER SUSCEPTIBILITY; CELL LINE; CELL MUTANT; CELL NUCLEUS; CHROMATIN STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; DNA REPAIR; FANCONI ANEMIA; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATOR GENE;

EID: 0035510108     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.23.2651     Document Type: Article

References (74)

1. The emerging genetic and molecular basis of Fanconi anaemia
2. Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents
3. Induction by alkylating agents of sister chromatid exchanges and chromatid breaks in Fanconi's anemia
4. Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment
5. Cancer-susceptibility genes. Gatekeepers and caretakers
6. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9
7. Classification of Fanconi anemia patients by complementation analysis: Evidence for fifth genetic subtype
8. Evidence for at least eight Fanconi anemia genes
9. Complementation analysis in Fanconi anemia: Assignment of the reference FA-H patient to group A
10. Cloning of cDNA for Fanconi's anemia by functional complementation
11. Expression cloning of a cDNA for the major Fanconi anaemia gene
12. Fanconi Anemia/Breast Cancer Consortium Positional cloning of Fanconi anemia group A gene
13. The Fanconi anaemia group G gene FANCG is identical with XRCC9
14. The Fanconi anemia gene FANCF encodes a novel protein with homology to ROM
15. Isolation of a cDNA representing the Fanconi anemia complementation group E gene
16. Positional cloning of a novel Fanconi anemia gene, FANCD2
17. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription
18. Genes affecting the regulation of SUC2 gene expression by glucose repression in Saccharomyces cerevisiae
19. Five SWI genes are required for expression of the HO gene in yeast
20. Dosage-dependent modifiers of polycomb and antennapedia mutations in Drosophila
21. brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2
22. Functional analysis of the DNA-stimulated ATPase domain of yeast SWI2/SNF2
23. Cell cycle control of the yeast HO gene: Cis- and trans-acting regulators
24. A multisubunit complex containing the SWI/ADR6, SWI2/SNF2, SWI3, SNF5 and SNF6 gene products isolated from yeast
25. Chromatin and gene expression: Constant questions, but changing answers
26. SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2
27. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex
28. p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes
29. Diversity and specialization of mammalian SWI/SNF complexes
30. The SWI/SNFI family of global transcriptional activators
31. The SWI-SNF complex: A chromatin remodeling machine?
32. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex
33. Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex
34. Nucleosome disruption and enhancement of activator binding by a human SWI/SNF complex
35. Catalytic activity of the yeast SWI/SNF complex on reconstituted nucleosome arrays
36. Human SWI/SNF interconverts a nucleosome between its base and a stable remodeled state
37. Two human homologues of Saccharomyces cerevisiae SWI/SNF2 complex and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic receptor
38. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest
39. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor
40. Functional interactions between the hBRM/hBRGI transcriptional activators and the pRB family of proteins
41. RB and hbrm cooperate to repress the activation functions of E2F1
42. BRG-1 is required for RB-mediated cell cycle arrest
43. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF
44. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression
45. Nuclear receptors: Coactivators, corepressors and chromatin remodeling in the control of transcription
46. Control of histone modifications
47. Roles of histone acetyltransferases and deacetylases in gene regulation
48. Coactivator and corepressor complexes in nuclear receptor function
49. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF
50. Chromatin remodeling and leukemia: New therapeutic paradigms
51. Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96
52. Immunotherapy of cancers with autologous cancer-derived heat shock protein preparations
53. A C-terminal signal prevents secretion of luminal ER proteins
54. GRP94, an ER chaperone with protein and peptide binding properties
55. 2+-ionophore-regulated proteins
56. The 90 kDa heat shock protein (hsp90) induces the condensation of the chromatin structure
57. Interactions of Hsp90 with histones and related peptides
58. A C/EBPβ isoform recruits the SWI/SNF complex to activate myeloid genes
59. Fanconi anemia proteins FANCA, FANCC and FANCG/XRCC9 interact in a functional nuclear complex
60. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA
61. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG
62. The Fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex
63. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway
64. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC unclear accumulation
65. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
66. BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer
67. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner
68. The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis
69. Systematic peptide fragmentation of polyvinylidene difluoride (PVDF)-immobilized proteins prior to microsequencing
70. S-carboxymethylation of proteins transferred onto polyvinylidene difluoride membranes followed by in situ protease digestion and amino acid microsequencing
71. Delayed extraction improves specificity in database searches by matrix-assisted laser desorption/ionization peptide maps
72. Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes
73. Stable co-occupancy of transcription factor and histones at HIV-1 enhancer
74. Octamer transfer and creation of stably remodeled nucleasomes by human SWI-SNF and its isolated ATPases